查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598758

臍帶血處理產品市場：按產品、最終用戶分類 - 全球預測 2025-2030 年

Umbilical Cord Blood Processing Products Market by Product (CD Markers, Cell Culture Devices, Cell Culture Reagents), End-Users (Private Banks, Public Banks) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

臍帶血加工產品市場2023年估值為15.3億美元，預計到2024年將達到16.9億美元，複合年成長率為10.93%，到2030年將達到31.6億美元。

臍帶血加工產品包括用於採集、處理、儲存和冷凍保存臍帶血來源的造血幹細胞（造血幹細胞）的各種技術和設備。由於幹細胞在治療各種危及生命的疾病（例如白血病、淋巴瘤和免疫性疾病）的應用越來越多，為骨髓移植提供了替代方案，因此該市場至關重要。其應用和最終用途正在擴展到專注於再生醫學和個人化治療的醫院、研究機構和治療中心。影響市場的主要成長要素包括幹細胞治療意識的提高、生物技術的進步以及對臍帶血庫的監管支持。隨著公共和私人臍帶血銀行在全球擴大服務範圍，對這些產品的需求預計將激增。機會包括開發自動化和高效的處理技術以提高幹細胞活力和產量，以及擴大收集網路以增加捐贈者多樣性。然而，高昂的營運成本、嚴格的研究法規以及幹細胞研究和治療的倫理問題給市場成長帶來了挑戰。其他限制包括發展中地區缺乏認知以及適當臍帶血採集和儲存的基礎設施不足。專注於改進冷凍保存技術和新穎的細胞分離方法的創新為市場擴張提供了一個有希望的途徑。此外，合作研究可以顯著促進對臍帶血幹細胞治療潛力的了解。由於技術進步和醫療保健範式的變化，這個市場的性質正在迅速發展。公司可以透過投資研發以及與醫療保健提供者和研究機構建立策略夥伴關係關係來利用這些動態。總體而言，重點解決監管挑戰和提高社會意識對於維持臍帶血加工產品市場的成長至關重要。

主要市場統計
基準年[2023] 15.3億美元
預測年份 [2024] 16.9億美元
預測年份 [2030] 31.6億美元
複合年成長率（%） 10.93%

市場動態：快速發展的臍帶血加工產品市場的關鍵市場洞察

供需的動態交互作用正在改變臍帶血加工產品市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病增加導致的成長
    • 提高人們對臍帶儲存應用的認知的公共和私人宣傳活動進展順利
    • 血液疾病和血癌的盛行率增加
  • 市場限制因素
    • 建立臍帶血庫中心高成本
  • 市場機會
    • 推出新的臍帶血加工產品
    • 政府對臍帶血幹細胞研究和臨床試驗的有利投資
  • 市場挑戰
    • 缺乏原料和熟練的專業人員

波特五力：駕馭臍帶血加工產品市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解臍帶血加工產品市場的外部影響

外部宏觀環境因素在塑造臍帶血加工產品市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解臍帶血加工產品市場的競爭狀況

對臍帶血處理產品市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣臍帶血處理產品市場供應商的績效評估

FPNV 定位矩陣是評估臍帶血加工產品市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了臍帶血加工產品市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對臍帶血加工產品市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於慢性病增加而增加
      • 有利的公共和私人宣傳活動，以提高人們對臍帶庫應用的認知
      • 血液疾病和血癌的發生率增加
    • 抑制因素
      • 建立臍帶血庫中心的成本很高。
    • 機會
      • UC 血液處理產品新產品上市的出現
      • 政府對臍帶血幹細胞研究和臨床試驗的有利投資
    • 任務
      • 缺乏原料和熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章臍帶血加工產品市場：依產品

  • CD標記
  • 細胞培養裝置
  • 細胞培養試劑
  • 相容的袋子和重疊
  • 臍帶血採集系統
  • 傳輸、加工、冷凍集
  • 輸血器
  • 超低溫液態氮冷凍庫
  • 洗衣套裝

第7章臍帶血處理產品市場：依最終用戶分類

  • 私人銀行
  • 公營銀行

第8章北美與南美臍帶血加工產品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區臍帶血加工產品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲臍帶血加工產品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abcam PLC
  • BioLegend, Inc.
  • Biologics International Corp.
  • Cryo-Cell International, Inc.
  • Immucor, Inc.
  • Nikkiso Co., Ltd.
  • Novus Biologicals
  • Pall Corporation
  • Prospec-Tany Technogene Ltd.
  • Proteintech Group, Inc.
  • Sartorius AG
  • Sino Biological Inc.
  • ViroGen
Product Code: MRR-6849E8ED80B7

The Umbilical Cord Blood Processing Products Market was valued at USD 1.53 billion in 2023, expected to reach USD 1.69 billion in 2024, and is projected to grow at a CAGR of 10.93%, to USD 3.16 billion by 2030.

Umbilical cord blood processing products encompass a range of technologies and equipment used for the collection, processing, storage, and cryopreservation of hematopoietic stem cells (HSCs) derived from umbilical cord blood. This market is crucial due to the increasing application of stem cells in treating various life-threatening diseases like leukemia, lymphoma, and immune disorders, providing an alternative to bone marrow transplants. The application and end-use scope extend to hospitals, research institutes, and therapeutic centers focusing on regenerative medicine and personalized treatments. Key growth factors influencing the market include the rising awareness of stem cell therapies, advancements in biotechnology, and regulatory support for cord blood banking. The demand for these products is expected to surge as public and private cord blood banks expand their services globally. Opportunities lie in developing automated and efficient processing technologies to enhance the viability and yield of stem cells, along with expanding collection networks to increase donor diversity. However, market growth is challenged by high operational costs, stringent regulatory requirements, and ethical concerns surrounding stem cell research and therapy. Limitations also include the lack of awareness in developing regions and inadequate infrastructure for proper cord blood collection and storage. Innovations focusing on improving cryopreservation techniques and novel cell separation methods offer promising avenues for market expansion. Furthermore, collaborative research initiatives could unlock substantial advancements in understanding the therapeutic potential of umbilical cord blood-derived stem cells. The nature of this market is rapidly evolving, driven by technological advances and changing healthcare paradigms. Businesses can leverage these dynamics by investing in R&D and forming strategic partnerships with healthcare providers and research institutions. Overall, maintaining strong focus on addressing regulatory challenges and increasing public awareness is essential for sustaining growth in the umbilical cord blood processing products market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.53 billion
Estimated Year [2024] USD 1.69 billion
Forecast Year [2030] USD 3.16 billion
CAGR (%) 10.93%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Umbilical Cord Blood Processing Products Market

The Umbilical Cord Blood Processing Products Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing due to the increasing prevalence of chronic diseases
    • Favorable public and private campaigns generating awareness regarding applications of cord banking
    • Increasing prevalence of hematological disorders and blood cancer
  • Market Restraints
    • High cost for setting up cord blood banking centers
  • Market Opportunities
    • Emergence of new product launches of UC blood processing products
    • Favorable government investments in research and clinical trials of cord blood stem cells
  • Market Challenges
    • Lack of raw materials and skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Umbilical Cord Blood Processing Products Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Umbilical Cord Blood Processing Products Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Umbilical Cord Blood Processing Products Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Umbilical Cord Blood Processing Products Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Umbilical Cord Blood Processing Products Market

A detailed market share analysis in the Umbilical Cord Blood Processing Products Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Umbilical Cord Blood Processing Products Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Umbilical Cord Blood Processing Products Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Umbilical Cord Blood Processing Products Market

A strategic analysis of the Umbilical Cord Blood Processing Products Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Umbilical Cord Blood Processing Products Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, BioLegend, Inc., Biologics International Corp., Cryo-Cell International, Inc., Immucor, Inc., Nikkiso Co., Ltd., Novus Biologicals, Pall Corporation, Prospec-Tany Technogene Ltd., Proteintech Group, Inc., Sartorius AG, Sino Biological Inc., and ViroGen.

Market Segmentation & Coverage

This research report categorizes the Umbilical Cord Blood Processing Products Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across CD Markers, Cell Culture Devices, Cell Culture Reagents, Compatible Bags & Over Wraps, Cord Blood Collection Systems, Transfer, Processing & Freezing Sets, Transfusion Sets, Ultra-Cold Liquid Nitrogen Freezers, and Washing Sets.
  • Based on End-Users, market is studied across Private Banks and Public Banks.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing due to the increasing prevalence of chronic diseases
      • 5.1.1.2. Favorable public and private campaigns generating awareness regarding applications of cord banking
      • 5.1.1.3. Increasing prevalence of hematological disorders and blood cancer
    • 5.1.2. Restraints
      • 5.1.2.1. High cost for setting up cord blood banking centers
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of new product launches of UC blood processing products
      • 5.1.3.2. Favorable government investments in research and clinical trials of cord blood stem cells
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of raw materials and skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Umbilical Cord Blood Processing Products Market, by Product

  • 6.1. Introduction
  • 6.2. CD Markers
  • 6.3. Cell Culture Devices
  • 6.4. Cell Culture Reagents
  • 6.5. Compatible Bags & Over Wraps
  • 6.6. Cord Blood Collection Systems
  • 6.7. Transfer, Processing & Freezing Sets
  • 6.8. Transfusion Sets
  • 6.9. Ultra-Cold Liquid Nitrogen Freezers
  • 6.10. Washing Sets

7. Umbilical Cord Blood Processing Products Market, by End-Users

  • 7.1. Introduction
  • 7.2. Private Banks
  • 7.3. Public Banks

8. Americas Umbilical Cord Blood Processing Products Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Umbilical Cord Blood Processing Products Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Umbilical Cord Blood Processing Products Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. BioLegend, Inc.
  • 3. Biologics International Corp.
  • 4. Cryo-Cell International, Inc.
  • 5. Immucor, Inc.
  • 6. Nikkiso Co., Ltd.
  • 7. Novus Biologicals
  • 8. Pall Corporation
  • 9. Prospec-Tany Technogene Ltd.
  • 10. Proteintech Group, Inc.
  • 11. Sartorius AG
  • 12. Sino Biological Inc.
  • 13. ViroGen

LIST OF FIGURES

  • FIGURE 1. UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET RESEARCH PROCESS
  • FIGURE 2. UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET DYNAMICS
  • TABLE 7. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY CD MARKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY CELL CULTURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY CELL CULTURE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COMPATIBLE BAGS & OVER WRAPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY CORD BLOOD COLLECTION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY TRANSFER, PROCESSING & FREEZING SETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY TRANSFUSION SETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY ULTRA-COLD LIQUID NITROGEN FREEZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY WASHING SETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRIVATE BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PUBLIC BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 106. UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. UMBILICAL CORD BLOOD PROCESSING PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023